Skip to main content
CAI logo

CAI · Caris Life Sciences, Inc. · Share Buybacks

Track CAI — free
$17.58 -0.96 (-5.18%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$5.04B
Shares
286.78M
Volume · Nov 20 4.57M Avg daily vol (3M) 4.64M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$100,000,000
as of 2026-11-04 · from 8-K (reviewed)
Remaining Authorization
$72,100,000
as of 2026-11-04 · from 8-K (reviewed)
Program Utilization
27.9% $27,900,000 used of $100,000,000
Program Announced Authorized Remaining Runs Through
2026-08-05 $100,000,000 $72,100,000 —

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $31,371,000
2025-12-31 $113,000
Key facts CIK 2019410 CUSIP 142152107 13F (30d) 312 filings 296 filers Visit website Investor relations